US2021388408A1PendingUtilityA1

Cell culture process for making a glycoprotein

Assignee: REGENERON PHARMAPriority: Jul 6, 2017Filed: Aug 23, 2021Published: Dec 16, 2021
Est. expiryJul 6, 2037(~10.9 yrs left)· nominal 20-yr term from priority
C12N 2500/32C12N 2510/02C12N 2500/36C12N 2500/46C07K 2319/30C12N 5/0682C12N 15/85C07K 14/71C07K 2317/41C07K 16/22C07K 16/40C07K 16/2866C12P 21/005C12N 5/0018C12P 21/06C07K 14/415C07K 14/7155C07K 14/4705C07K 2319/32
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The instant application provides a method for screening batches of soy hydrolysate for a desired amount of a component thereof, such as ornithine or putrescine, and selecting only those batches of soy hydrolysate that have a desired amount of such component. The present disclosure also sets forth methods for culturing cells in media supplemented with selected batches of soy to produce more consistent, high quality lots of a protein of interest. Further, the present disclosure provides a plurality of protein preparations that have each been produced by culturing cells in media supplemented with separate batches of soy hydrolysate containing a desired amount of ornithine or putrescine, whereby each batch of protein produced exhibits improved quality of the protein of interest or amount of quality protein produced.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method comprising:
 a. enzymatically digesting soy extract in a residue-free reaction vessel to manufacture a soy hydrolysate;   b. measuring the amount of ornithine or putrescine in the soy hydrolysate; and   c. selecting soy hydrolysate with ≤0.067% (w/w) ornithine or putrescine for use in a cell culture media.

Join the waitlist — get patent alerts

Track US2021388408A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.